Cargando…
Synergistic activity of sorafenib and betulinic acid against clonogenic activity of non‐small cell lung cancer cells
The highly selective multi‐targeted agent sorafenib is an inhibitor of a number of intracellular signaling kinases with anti‐proliferative, anti‐angiogenic and pro‐apoptotic effects in various types of tumors, including human non‐small cell lung cancer (NSCLC). Betulin displays a broad spectrum of b...
Autores principales: | Kutkowska, Justyna, Strzadala, Leon, Rapak, Andrzej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666031/ https://www.ncbi.nlm.nih.gov/pubmed/28846180 http://dx.doi.org/10.1111/cas.13386 |
Ejemplares similares
-
Sorafenib in Combination with Betulinic Acid Synergistically Induces Cell Cycle Arrest and Inhibits Clonogenic Activity in Pancreatic Ductal Adenocarcinoma Cells
por: Kutkowska, Justyna, et al.
Publicado: (2018) -
The mitochondrial localization of RelB and NFATx in immature T cells
por: Stasik, Izabela, et al.
Publicado: (2008) -
Antileishmanial Activity of Semisynthetic Lupane Triterpenoids Betulin and Betulinic Acid Derivatives: Synergistic Effects with Miltefosine
por: Sousa, Maria C., et al.
Publicado: (2014) -
Long-lasting reduction in clonogenic potential of colorectal cancer cells by sequential treatments with 5-azanucleosides and topoisomerase inhibitors
por: Pawlak, Alicja, et al.
Publicado: (2016) -
An Antibody Specific for the Dog Leukocyte Antigen DR (DLA-DR) and Its Novel Methotrexate Conjugate Inhibit the Growth of Canine B Cell Lymphoma
por: Lisowska, Marta, et al.
Publicado: (2019)